Home › Pinealoma
Pag-aaral pangklinika para sa Pinealoma na nagre-recruit sa U.S.
8 pag-aaral para sa Pinealoma ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors
Nagre-recruitPhase 1
Edad 5 hanggang 18 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT06357377GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 11, 2026 · NCT07087002B7-H3.CD28Z.CART in CNS Neoplasms
Nagre-recruitPhase 1
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07390539Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)
Nagre-recruitPhase 1
Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT06193759A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.
Nagre-recruitMaagang Phase 1
Edad 3 hanggang 21 · Lahat ng kasarian · Na-update Abr 29, 2026 · NCT07017816Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Nagre-recruitPhase 1
Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Abr 13, 2026 · NCT04185038Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Dis 18, 2025 · NCT04541082International PPB/DICER1 Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
0 Minutes – 100 Years · Lahat ng kasarian · Na-update Ene 30, 2025 · NCT03382158Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.